All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ICUI / ICU Medical, Inc.
|
|
|
|
|
|
|
|
| VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| GMTX / Gemini Therapeutics Inc
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| AMHCW / Amplitude Healthcare Acquisition Corp - Warrants (01/12/2026)
|
|
|
|
|
|
|
|
| MICT / M&I Capital Trust B - Preferred Security
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TMPMU / Turmeric Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
| CHAQ.WS / Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRDF / Cardiff Oncology, Inc.
|
|
|
|
|
|
|
|
| ONCT / Oncternal Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VRCA / Verrica Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
| SMFR / Sema4 Holdings Corp - Class A
|
|
|
|
|
|
|
|
| US7786732021 / Roth Ch Acquisition II Co.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| EPE / Epizyme Inc
|
|
|
|
|
|
|
|
| AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| NMTR / 9 Meters Biopharma Inc
|
|
|
|
|
|
|
|
| LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| US92731L1145 / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| XENT / Intersect ENT Inc
|
|
|
|
|
|
|
|
| VERO / Venus Concept Inc.
|
|
|
|
|
|
|
|
| GLEO.WS / Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
|
|
|
|
|
|
|
|
| SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
| JYAC / Jiya Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
| HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| / Cerevel Therapeutics Holdings, Inc. Warrant
|
|
|
|
|
|
|
|
| US6837121119 / Opendoor Technologies Inc Warrants expiring 12/18/2025
|
|
|
|
|
|
|
|
| US87105M1100 / Switchback Energy Acquisition Corp Warrants
|
|
|
|
|
|
|
|
| / EyePoint Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| LYRA / Lyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
| COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| HAE / Haemonetics Corporation
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
| SRSAU / Sarissa Capital Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
| KBNT / Kubient, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TILS / TIZIANA LIFE SCIENCES PLC
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| IMTXW / Immatics N.V. - Equity Warrant
|
|
|
|
|
|
|
|
| SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
| VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
| EUCRU / Eucrates Biomedical Acquisition Corp
|
|
|
|
|
|
|
|
| KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
| GNPX / Genprex, Inc.
|
|
|
|
|
|
|
|
| NAUT / Nautilus Biotechnology, Inc.
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| OEG / Orbital Energy Group Inc
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| NNDM / Nano Dimension Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US30258N1211 / WARRANT
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| OCUP / Opus Genetics, Inc.
|
|
|
|
|
|
|
|
| CNSP / CNS Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
